MXPA05007771A - Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist. - Google Patents

Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist.

Info

Publication number
MXPA05007771A
MXPA05007771A MXPA05007771A MXPA05007771A MXPA05007771A MX PA05007771 A MXPA05007771 A MX PA05007771A MX PA05007771 A MXPA05007771 A MX PA05007771A MX PA05007771 A MXPA05007771 A MX PA05007771A MX PA05007771 A MXPA05007771 A MX PA05007771A
Authority
MX
Mexico
Prior art keywords
antagonist
methods
joint pain
improving sleep
treating joint
Prior art date
Application number
MXPA05007771A
Other languages
Spanish (es)
Inventor
Charles David Petrie
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MXPA05007771A publication Critical patent/MXPA05007771A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Abstract

The present invention provides methods, pharmaceutical compositions and kits for treating joint pain and/or improving sleep using a SERM of formula (I): wherein the variables A, B, D, E, e, G, Y and Z 1 are as defined in the specification.
MXPA05007771A 2003-01-22 2004-01-09 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist. MXPA05007771A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44183003P 2003-01-22 2003-01-22
PCT/IB2004/000093 WO2004064832A2 (en) 2003-01-22 2004-01-09 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist

Publications (1)

Publication Number Publication Date
MXPA05007771A true MXPA05007771A (en) 2005-09-30

Family

ID=32771981

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05007771A MXPA05007771A (en) 2003-01-22 2004-01-09 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist.

Country Status (8)

Country Link
US (1) US20040152713A1 (en)
EP (1) EP1599199A2 (en)
JP (1) JP2006516276A (en)
BR (1) BRPI0406596A (en)
CA (1) CA2513432A1 (en)
MX (1) MXPA05007771A (en)
TW (1) TW200505896A (en)
WO (1) WO2004064832A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060198872A1 (en) * 2005-03-07 2006-09-07 Chioma Ikonte Plant based dietary supplement for improving the duration and quality of sleep
US20070099882A1 (en) * 2005-10-27 2007-05-03 Gurney Harry C Methods and compositions for prolonged alleviation of articular joint pain
US20100048713A1 (en) * 2006-01-06 2010-02-25 Aarhus Universitet Compounds acting on the serotonin transporter
JP5528105B2 (en) * 2006-06-05 2014-06-25 オースペックス・ファーマシューティカルズ・インコーポレイテッド Preparation and utilization of substituted imidazopyridine compounds with hypnotic effect
US20070298117A1 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Compositions and kits comprising a melatonin component and a chondroprotective component
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
WO2011159769A2 (en) 2010-06-17 2011-12-22 Aragon Pharmaceuticals, Inc. Indane estrogen receptor modulators and uses thereof
EP2793853B1 (en) * 2011-12-23 2015-12-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical formulations of flurbiprofen and glucosamin
US20150359814A1 (en) * 2013-01-28 2015-12-17 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical Combinations of Flurbiprofen, Glucosamin and Capsaicin
AU2014306759B2 (en) 2013-08-12 2018-04-26 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2016010771A1 (en) 2014-07-17 2016-01-21 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
WO2016107894A1 (en) * 2014-12-31 2016-07-07 Sanovel Ilac Sanayi Ve Ticaret A.S. Composition for joint and cartilage disorders comprising flurbiprofen, glucosamine sulfate, chondroitin sulfate, hyaluronic acid and methylsulfonylmethane
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions
US20210282668A1 (en) 2020-03-16 2021-09-16 Koninklijke Philips N.V. Non-invasive determination of airway resistance

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
TW442286B (en) * 1996-02-28 2001-06-23 Pfizer New therapeutic uses of estrogen agonists
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US5880137A (en) * 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
US5780497A (en) * 1996-04-19 1998-07-14 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
US5985910A (en) * 1996-04-19 1999-11-16 American Home Products Corporation 3- [4- (2- Phenyl-Indole-1-ylmethyl) Phenyl]- Acrylamides as estrogenic agents
US5958418A (en) * 1997-01-22 1999-09-28 Johnson Prillerman; Kathleen O. External herbal composition for treating muscle aches and joint pain
JP3766165B2 (en) * 1997-03-07 2006-04-12 株式会社ニコン Image forming method and photosensitive material
CA2267049A1 (en) * 1999-02-05 2000-08-05 Bioglan Laboratories Ltd. Pharmaceutical compositions
CO5271709A1 (en) * 2000-01-12 2003-04-30 Pfizer Prod Inc COMPOSITIONS AND PROCEDURES FOR THE AND TREATMENT OF AFFECTIONS RESPONDING TO STROGENS
EP1192945A3 (en) * 2000-09-21 2004-03-03 Pfizer Products Inc. Use of an estrogen agonist/antagonist for treating osteoarthritis

Also Published As

Publication number Publication date
CA2513432A1 (en) 2004-08-05
TW200505896A (en) 2005-02-16
JP2006516276A (en) 2006-06-29
WO2004064832A2 (en) 2004-08-05
EP1599199A2 (en) 2005-11-30
US20040152713A1 (en) 2004-08-05
WO2004064832A3 (en) 2004-12-16
BRPI0406596A (en) 2005-12-20

Similar Documents

Publication Publication Date Title
MXPA05007771A (en) Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist.
AU2002213336A1 (en) Substituted heterocyclic compounds for treating multidrug resistance
MXPA05002442A (en) Imidazolopyridines and methods of making and using the same.
MY162174A (en) Azetidines mek inhibitors for the treatment of proliferative diseases
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
MY137535A (en) New pyrrolidinium derivatives
UA93351C2 (en) Phthalazine derivatives as parp inhibitors
CA2603830A1 (en) Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
GEP20084488B (en) Use of therapeutic agents for treating pain
MXPA03010961A (en) Thiazole compounds useful as inhibitors of protein kinases.
PT1984357E (en) 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
IL195256A0 (en) Compositions of r(+)and s(-)pramipexole and methods of using the same
DE602004021472D1 (en) Pyrimiidinverbindungen
EP1765335A4 (en) Pyrazole amide derivatives, compositions containing such compounds and methods of use
HK1155146A1 (en) Indene derivatives as pharmaceutical agents
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
IL172542A0 (en) 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
SG167670A1 (en) Aminocyclohexyl ether compounds and uses thereof
EP1572118A4 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
MY141011A (en) Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
MXPA04004477A (en) Nk1 antagonists.
MXPA03007413A (en) Composition and method for treating inflammatory disorders.
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
IL161040A0 (en) Spreadable compositions for topical use, an improved process of making same and methods of using same

Legal Events

Date Code Title Description
FA Abandonment or withdrawal